Joshua H. Bilenker Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joshua H. Bilenker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joshua H. Bilenker. Joshua H. Bilenker is Director in T2 Biosystems, Inc. ($TTOO) and President & CEO in Loxo Oncology, Inc. ($LOXO) and Director in ViewRay, Inc. ($VRAY) and Director in Gossamer Bio, Inc. ($GOSS) and Director in Sana Biotechnology, Inc. ($SANA).
Latest Insider Trading Transactions of Joshua H. Bilenker
Sentiment: All, GOSS, LOXO, SANA, TTOO, VRAY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 14,690 | |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 22,190 | |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 138.89 | 1,803 | 250,416 | 182,707 | 184.5 K to 182.7 K (-0.98 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 138.35 | 3,297 | 456,147 | 184,510 | 187.8 K to 184.5 K (-1.76 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 136.72 | 400 | 54,688 | 187,807 | 188.2 K to 187.8 K (-0.21 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 135.83 | 1,000 | 135,828 | 188,207 | 189.2 K to 188.2 K (-0.53 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 134.41 | 300 | 40,322 | 189,207 | 189.5 K to 189.2 K (-0.16 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 133.11 | 700 | 93,175 | 189,507 | 190.2 K to 189.5 K (-0.37 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 139.00 | 100 | 13,900 | 182,707 | 182.8 K to 182.7 K (-0.05 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.83 | 167 | 23,018 | 182,807 | 183 K to 182.8 K (-0.09 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.28 | 1,558 | 213,876 | 182,974 | 184.5 K to 183 K (-0.84 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 136.22 | 1,525 | 207,730 | 184,532 | 186.1 K to 184.5 K (-0.82 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 135.08 | 2,050 | 276,920 | 186,057 | 188.1 K to 186.1 K (-1.09 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 134.18 | 2,000 | 268,369 | 188,107 | 190.1 K to 188.1 K (-1.05 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 132.58 | 100 | 13,258 | 190,107 | 190.2 K to 190.1 K (-0.05 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 14,690 | |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 22,190 | |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 138.89 | 1,803 | 250,416 | 182,707 | 184.5 K to 182.7 K (-0.98 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 138.35 | 3,297 | 456,147 | 184,510 | 187.8 K to 184.5 K (-1.76 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 136.72 | 400 | 54,688 | 187,807 | 188.2 K to 187.8 K (-0.21 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 135.83 | 1,000 | 135,828 | 188,207 | 189.2 K to 188.2 K (-0.53 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 134.41 | 300 | 40,322 | 189,207 | 189.5 K to 189.2 K (-0.16 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 133.11 | 700 | 93,175 | 189,507 | 190.2 K to 189.5 K (-0.37 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 139.00 | 100 | 13,900 | 182,707 | 182.8 K to 182.7 K (-0.05 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.83 | 167 | 23,018 | 182,807 | 183 K to 182.8 K (-0.09 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.28 | 1,558 | 213,876 | 182,974 | 184.5 K to 183 K (-0.84 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 136.22 | 1,525 | 207,730 | 184,532 | 186.1 K to 184.5 K (-0.82 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 135.08 | 2,050 | 276,920 | 186,057 | 188.1 K to 186.1 K (-1.09 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 134.18 | 2,000 | 268,369 | 188,107 | 190.1 K to 188.1 K (-1.05 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 132.58 | 100 | 13,258 | 190,107 | 190.2 K to 190.1 K (-0.05 %) |
| May 16 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 29,690 | |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 37,190 | |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 132.53 | 100 | 13,253 | 182,707 | 182.8 K to 182.7 K (-0.05 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 131.84 | 3,400 | 448,262 | 182,807 | 186.2 K to 182.8 K (-1.83 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 130.71 | 2,400 | 313,709 | 186,207 | 188.6 K to 186.2 K (-1.27 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 129.44 | 800 | 103,555 | 188,607 | 189.4 K to 188.6 K (-0.42 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 128.31 | 800 | 102,644 | 189,407 | 190.2 K to 189.4 K (-0.42 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 133.49 | 510 | 68,077 | 182,707 | 183.2 K to 182.7 K (-0.28 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 132.54 | 2,490 | 330,031 | 183,217 | 185.7 K to 183.2 K (-1.34 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 131.76 | 1,500 | 197,635 | 185,707 | 187.2 K to 185.7 K (-0.80 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 130.62 | 1,283 | 167,590 | 187,207 | 188.5 K to 187.2 K (-0.68 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 129.35 | 1,717 | 222,097 | 188,490 | 190.2 K to 188.5 K (-0.90 %) |
| Apr 26 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 44,690 | |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 52,190 | |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 132.26 | 1,400 | 185,157 | 182,707 | 184.1 K to 182.7 K (-0.76 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 131.60 | 4,300 | 565,873 | 184,107 | 188.4 K to 184.1 K (-2.28 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 130.66 | 1,800 | 235,185 | 188,407 | 190.2 K to 188.4 K (-0.95 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 133.50 | 1,491 | 199,055 | 182,707 | 184.2 K to 182.7 K (-0.81 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 132.58 | 1,094 | 145,040 | 184,198 | 185.3 K to 184.2 K (-0.59 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 131.76 | 1,715 | 225,968 | 185,292 | 187 K to 185.3 K (-0.92 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 130.69 | 1,800 | 235,243 | 187,007 | 188.8 K to 187 K (-0.95 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 129.97 | 1,100 | 142,963 | 188,807 | 189.9 K to 188.8 K (-0.58 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 128.57 | 300 | 38,572 | 189,907 | 190.2 K to 189.9 K (-0.16 %) |
| Mar 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 74,690 | |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 82,190 | |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 89.52 | 2,682 | 240,106 | 182,707 | 185.4 K to 182.7 K (-1.45 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 88.89 | 2,672 | 237,520 | 185,389 | 188.1 K to 185.4 K (-1.42 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 87.14 | 1,042 | 90,802 | 188,061 | 189.1 K to 188.1 K (-0.55 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 86.19 | 1,104 | 95,157 | 189,103 | 190.2 K to 189.1 K (-0.58 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 90.50 | 800 | 72,397 | 182,707 | 183.5 K to 182.7 K (-0.44 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 89.94 | 1,577 | 141,833 | 183,507 | 185.1 K to 183.5 K (-0.85 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 88.78 | 600 | 53,266 | 185,084 | 185.7 K to 185.1 K (-0.32 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 87.12 | 1,604 | 139,748 | 185,684 | 187.3 K to 185.7 K (-0.86 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 86.42 | 2,919 | 252,270 | 187,288 | 190.2 K to 187.3 K (-1.53 %) |
| Jan 18 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Jan 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | A | 84.88 | 300,000 | 25,464,000 | 300,000 | |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 89,690 | |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 97,190 | |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 82.86 | 200 | 16,572 | 182,707 | 182.9 K to 182.7 K (-0.11 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 81.72 | 100 | 8,172 | 182,907 | 183 K to 182.9 K (-0.05 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 80.88 | 600 | 48,529 | 183,007 | 183.6 K to 183 K (-0.33 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 80.08 | 609 | 48,770 | 183,607 | 184.2 K to 183.6 K (-0.33 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 78.99 | 3,023 | 238,796 | 184,216 | 187.2 K to 184.2 K (-1.61 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 78.06 | 2,268 | 177,050 | 187,239 | 189.5 K to 187.2 K (-1.20 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 76.93 | 700 | 53,849 | 189,507 | 190.2 K to 189.5 K (-0.37 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 84.29 | 2,000 | 168,587 | 182,707 | 184.7 K to 182.7 K (-1.08 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 83.42 | 2,900 | 241,912 | 184,707 | 187.6 K to 184.7 K (-1.55 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 82.55 | 2,600 | 214,621 | 187,607 | 190.2 K to 187.6 K (-1.37 %) |
| Dec 18 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 104,690 | |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 112,190 | |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 75.85 | 790 | 59,923 | 182,707 | 183.5 K to 182.7 K (-0.43 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 75.21 | 1,850 | 139,138 | 183,497 | 185.3 K to 183.5 K (-1.00 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 73.99 | 2,460 | 182,024 | 185,347 | 187.8 K to 185.3 K (-1.31 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 73.15 | 2,400 | 175,563 | 187,807 | 190.2 K to 187.8 K (-1.26 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 77.07 | 300 | 23,122 | 182,707 | 183 K to 182.7 K (-0.16 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 76.20 | 906 | 69,036 | 183,007 | 183.9 K to 183 K (-0.49 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 74.98 | 1,601 | 120,049 | 183,913 | 185.5 K to 183.9 K (-0.86 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 74.13 | 4,693 | 347,893 | 185,514 | 190.2 K to 185.5 K (-2.47 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 190,207 | 182.7 K to 190.2 K (+4.10 %) |
| Nov 29 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Gift | G | 0.00 | 6,000 | 0 | 182,707 | 188.7 K to 182.7 K (-3.18 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 119,690 | |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 127,190 | |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 87.67 | 200 | 17,533 | 188,707 | 188.9 K to 188.7 K (-0.11 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 86.65 | 4,339 | 375,994 | 188,907 | 193.2 K to 188.9 K (-2.25 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 86.18 | 2,961 | 255,175 | 193,246 | 196.2 K to 193.2 K (-1.51 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 196,207 | 188.7 K to 196.2 K (+3.97 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 88.77 | 812 | 72,084 | 188,707 | 189.5 K to 188.7 K (-0.43 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 87.74 | 998 | 87,563 | 189,519 | 190.5 K to 189.5 K (-0.52 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 86.88 | 5,690 | 494,320 | 190,517 | 196.2 K to 190.5 K (-2.90 %) |
| Nov 01 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 196,207 | 188.7 K to 196.2 K (+3.97 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 134,690 | |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 142,190 | |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 89.48 | 2,263 | 202,485 | 188,707 | 191 K to 188.7 K (-1.19 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 89.03 | 2,873 | 255,781 | 190,970 | 193.8 K to 191 K (-1.48 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 87.82 | 2,364 | 207,604 | 193,843 | 196.2 K to 193.8 K (-1.20 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 196,207 | 188.7 K to 196.2 K (+3.97 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 90.56 | 200 | 18,111 | 188,707 | 188.9 K to 188.7 K (-0.11 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 89.88 | 2,817 | 253,179 | 188,907 | 191.7 K to 188.9 K (-1.47 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 89.09 | 3,379 | 301,042 | 191,724 | 195.1 K to 191.7 K (-1.73 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 87.93 | 1,104 | 97,074 | 195,103 | 196.2 K to 195.1 K (-0.56 %) |
| Sep 20 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 196,207 | 188.7 K to 196.2 K (+3.97 %) |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 149,690 | |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 157,190 | |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 73.83 | 936 | 69,109 | 188,707 | 189.6 K to 188.7 K (-0.49 %) |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 73.33 | 6,564 | 481,334 | 189,643 | 196.2 K to 189.6 K (-3.35 %) |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 196,207 | 188.7 K to 196.2 K (+3.97 %) |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 74.12 | 2,483 | 184,046 | 188,707 | 191.2 K to 188.7 K (-1.30 %) |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 73.54 | 5,017 | 368,959 | 191,190 | 196.2 K to 191.2 K (-2.56 %) |
| Aug 16 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 196,207 | 188.7 K to 196.2 K (+3.97 %) |
| Mar 17 2017 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | A | 43.56 | 100,000 | 4,356,000 | 100,000 | |
| Dec 08 2016 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | A | 26.27 | 209,000 | 5,490,430 | 209,000 | |
| Sep 15 2016 | VRAY | ViewRay, Inc. | Bilenker Joshua H. | Director | Grant | A | 0.00 | 18,964 | 0 | 18,964 | 0 to 19 K |
| Jun 21 2016 | TTOO | T2 Biosystems, Inc ... | Bilenker Joshua H. | Director | Option Exercise | A | 8.56 | 17,647 | 151,058 | 17,647 | |
| Dec 18 2015 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | A | 31.69 | 142,000 | 4,499,980 | 142,000 | |
| Jun 23 2015 | TTOO | T2 Biosystems, Inc ... | Bilenker Joshua H. | Director | Option Exercise | A | 18.59 | 17,647 | 328,058 | 17,647 |